FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

395731001: Gliclazide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469671013 Gliclazide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489374016 Gliclazide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
59831000195119 gliclazide it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
814641000172110 gliclazide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
75361000195118 Gliclazid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gliclazide (substance) Is a Sulfonylurea (substance) false Inferred relationship Some
Gliclazide (substance) Is a Sulphonyluric hypoglycaemic true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Gliclazide 30mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Gliclazide (substance) Inferred relationship Some
Allergy to gliclazide (finding) Causative agent (attribute) False Gliclazide (substance) Inferred relationship Some
Product containing gliclazide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Gliclazide (substance) Inferred relationship Some 1
Gliclazide 80 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Gliclazide (substance) Inferred relationship Some
Gliclazide adverse reaction Causative agent (attribute) True Gliclazide (substance) Inferred relationship Some 1
Allergy to gliclazide (finding) Causative agent (attribute) True Gliclazide (substance) Inferred relationship Some 1
Product containing gliclazide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Gliclazide (substance) Inferred relationship Some 1
Gliclazide 80 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Gliclazide (substance) Inferred relationship Some 1
Gliclazide 80 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Gliclazide (substance) Inferred relationship Some 1
Product containing precisely gliclazide 30 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Gliclazide (substance) Inferred relationship Some 1
Product containing precisely gliclazide 30 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Gliclazide (substance) Inferred relationship Some 1
Gliclazide 80 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Gliclazide (substance) Inferred relationship Some 1
Product containing only gliclazide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Gliclazide (substance) Inferred relationship Some 1
Product containing only gliclazide in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Gliclazide (substance) Inferred relationship Some 1
Product containing precisely gliclazide 60 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Gliclazide (substance) Inferred relationship Some 1
Product containing precisely gliclazide 60 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Gliclazide (substance) Inferred relationship Some 1
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Gliclazide (substance) Inferred relationship Some 2
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Gliclazide (substance) Inferred relationship Some 2
Gliclazide- and metformin-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Gliclazide (substance) Inferred relationship Some 2
Gliclazide and metformin only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Gliclazide (substance) Inferred relationship Some 2
Product containing gliclazide and metformin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Gliclazide (substance) Inferred relationship Some 2
Product containing only gliclazide and metformin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Gliclazide (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start